159 related articles for article (PubMed ID: 28139275)
1. Liver X receptor activation inhibits PC-3 prostate cancer cells via the beta-catenin pathway.
Youlin K; Li Z; Weiyang H; Jian K; Siming L; Xin G
Pathol Res Pract; 2017 Mar; 213(3):267-270. PubMed ID: 28139275
[TBL] [Abstract][Full Text] [Related]
2. Suppression of beta-catenin signaling by liver X receptor ligands.
Uno S; Endo K; Jeong Y; Kawana K; Miyachi H; Hashimoto Y; Makishima M
Biochem Pharmacol; 2009 Jan; 77(2):186-95. PubMed ID: 18983830
[TBL] [Abstract][Full Text] [Related]
3. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
[TBL] [Abstract][Full Text] [Related]
4. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
5. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin.
Liang T; Ye X; Liu Y; Qiu X; Li Z; Tian B; Yan D
Exp Mol Med; 2018 Dec; 50(12):1-12. PubMed ID: 30532005
[TBL] [Abstract][Full Text] [Related]
6. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.
Yang CM; Lu YL; Chen HY; Hu ML
J Nutr Biochem; 2012 Sep; 23(9):1155-62. PubMed ID: 22137263
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of lncRNA MIR4435‑2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells
Xing P; Wang Y; Zhang L; Ma C; Lu J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846784
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
Chonlaket P; Wongwan T; Soodvilai S
Exp Physiol; 2018 Feb; 103(2):250-260. PubMed ID: 29127736
[TBL] [Abstract][Full Text] [Related]
9. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
10. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Park N; Baek HS; Chun YJ
PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
[TBL] [Abstract][Full Text] [Related]
11. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells.
Trasino SE; Kim YS; Wang TT
Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
Wang L; Zhao Y; Wu Q; Guan Y; Wu X
Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
[TBL] [Abstract][Full Text] [Related]
13. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators.
Endo-Umeda K; Aoyama A; Shimizu M; Ishikawa M; Hashimoto Y; Yamada S; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():136-148. PubMed ID: 28736297
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor activation reduces gastric cancer cell proliferation by suppressing Wnt signalling via LXRβ relocalization.
Wang Q; Feng F; Wang J; Ren M; Shi Z; Mao X; Zhang H; Ju X
J Cell Mol Med; 2019 Feb; 23(2):789-797. PubMed ID: 30338932
[TBL] [Abstract][Full Text] [Related]
15. [Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway].
Du YY; Liu X; Shan BE
Ai Zheng; 2009 May; 28(5):456-60. PubMed ID: 19624870
[TBL] [Abstract][Full Text] [Related]
16. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
17. β
Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C
Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines.
Chuu CP; Lin HP
Anticancer Res; 2010 Sep; 30(9):3643-8. PubMed ID: 20944148
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptors agonist T0901317 downregulates matrix metalloproteinase-9 expression in non-small-cell lung cancer by repressing nuclear factor-κB.
Chen QJ; Shi Y; Shi JF; Yuan ZH; Ma JY; Fang SR; Gu W
Anticancer Drugs; 2017 Oct; 28(9):952-958. PubMed ID: 28704236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]